As TMB has been associated with response to anti-PD-L1 inhibitors in NSCLC [59], we then examined the correlations between JADE2 mRNA and PD-L1 mRNA expression in LUAD and LUSC. Here, JADE2 is linked to non-small cell lung carcinoma.